Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure

Introduction: Human amnion-derived mesenchymal stem cells (hAMSCs) have been used in the treatment of acute myocardial infarction. In the current study, we investigated the efficacy of hAMSCs for the treatment of chronic model of myocardial ischemia and heart failure (HF) in rats. Methods: Male Wist...

Full description

Bibliographic Details
Main Authors: Fazel Gorjipour, Ladan Hosseini-Gohari, Alireza Alizadeh Ghavidel, Seyed Javad Hajimiresmaiel, Nasim Naderi, Amir Darbandi Azar, Hamidreza Pazoki-Toroudi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2019-03-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
Online Access:https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-11-35.pdf